Efficacy of oncolytic herpes virus G47. combined with immune checkpoint inhibitors in renal cell carcinoma models

被引：0
|
作者：
Sasaki, Kenichi [1 ,2 ]
Takeshima, Yuta [1 ]
Iwai, Miwako [1 ]
Fukuhara, Hiroshi [3 ]
Kume, Haruki [2 ]
Todo, Tomoki [1 ]
机构：
[1] IMSUT, Div Innovat Canc Therapy, Tokyo, Japan
[2] Univ Tokyo, Dept Urol, Fac Med, Tokyo, Japan
[3] Kyorin Univ, Sch Med, Dept Urol, Mitaka, Tokyo, Japan
来源：
CANCER SCIENCE | 2025年 / 116卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-3371
引用
收藏
页码：1571 / 1571
页数：1
相关论文
共 50 条
  • [41] Advanced Renal Cell Carcinoma: Tyrosine Kinase Inhibitors Versus Immune Checkpoint Inhibitors
    Rini, Brian I.
    ONCOLOGY-NEW YORK, 2022, 36 (08): : 511 - 515
  • [42] Combination of immune checkpoint inhibitors and tyrosine kinase inhibitors for the treatment of renal cell carcinoma
    Stuhler, Viktoria
    Rausch, Steffen
    Maas, Jan Moritz
    Stenzl, Arnulf
    Bedke, Jens
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2021, 21 (09) : 1215 - 1226
  • [43] Immune approaches beyond traditional immune checkpoint inhibitors for advanced renal cell carcinoma
    Jang, Albert
    Lichterman, Jake N.
    Zhong, Jeffrey Y.
    Shoag, Jonathan E.
    Garcia, Jorge A.
    Zhang, Tian
    Barata, Pedro C.
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2023, 19 (03)
  • [44] Relationship between sex and immune checkpoint inhibitors in urothelial carcinoma and renal cell carcinoma
    Yuxuan Song
    Yun Peng
    Caipeng Qin
    World Journal of Urology, 2023, 41 : 2301 - 2302
  • [45] Relationship between sex and immune checkpoint inhibitors in urothelial carcinoma and renal cell carcinoma
    Song, Yuxuan
    Peng, Yun
    Qin, Caipeng
    WORLD JOURNAL OF UROLOGY, 2023, 41 (08) : 2301 - 2302
  • [46] Construction of a novel immune response prediction signature to predict the efficacy of immune checkpoint inhibitors in clear cell renal cell carcinoma patients
    Yao, Jiannan
    Liang, Ziwei
    Duan, Ling
    Yang, G.
    Liu, Jian
    An, Guangyu
    HELIYON, 2023, 9 (06)
  • [47] Investigating the efficacy of immune checkpoint inhibitors in clear cell renal cell carcinoma based on methylation cross talk scoring
    Du, Qinglong
    Wang, Qiyuan
    Yang, Chen
    Wang, Yiping
    Yuan, Huiyang
    Zhang, Bing
    Ji, Hong
    Fu, Shuai
    Xue, Chunlei
    MEDICINE, 2025, 104 (11)
  • [48] Prognostic Models for Renal Cell Carcinoma in the Era of Immune Checkpoint Therapy
    Parosanu, Andreea
    Stanciu, Ioana Miruna
    Pirlog, Cristina
    Slavu, Cristina Orlov
    Cotan, Horia
    Iaciu, Cristian
    Popa, Ana Maria
    Olaru, Mihaela
    Moldoveanu, Oana
    Catalin, Baston
    Nitipir, Cornelia
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (10)
  • [49] The safety and efficacy of lenvatinib combined with immune checkpoint inhibitors therapy for advanced hepatocellular carcinoma
    Wang, Yun
    Jiang, Man
    Zhu, Jingjuan
    Qu, Jialin
    Qin, Kang
    Zhao, Deze
    Wang, Li
    Dong, Lina
    Zhang, Xiaochun
    BIOMEDICINE & PHARMACOTHERAPY, 2020, 132
  • [50] Efficacy and safety of immune checkpoint inhibitors alone or combined with chemotherapy in pulmonary sarcomatoid carcinoma
    Kaneda, H.
    Hazama, D.
    Kodama, H.
    Miyazaki, A.
    Azuma, K.
    Kawashima, Y.
    Sato, Y.
    Ito, K.
    Shiraishi, Y.
    Miura, K.
    Takahama, T.
    Oizumi, S.
    Namba, Y.
    Ikeda, S.
    Miura, S.
    Tachihara, M.
    ANNALS OF ONCOLOGY, 2022, 33 : S1573 - S1573
12345